These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exacerbation of extrapyramidal symptoms with paroxetine. Arya DK; McKenzie J; Worrall N Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063 [No Abstract] [Full Text] [Related]
7. Fluoxetine and extrapyramidal side effects. Am J Psychiatry; 1989 Oct; 146(10):1352-3. PubMed ID: 2604792 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of the efficacy of molindone and chlordiazepoxide in anxious outpatients. Carranza-Acevedo J; Tovar-Acosta H Curr Ther Res Clin Exp; 1972 Sep; 14(9):609-14. PubMed ID: 4628683 [No Abstract] [Full Text] [Related]
9. Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Mätzler W; Nägele T; Gasser T; Krüger R Neurology; 2007 Feb; 68(6):414. PubMed ID: 17283314 [No Abstract] [Full Text] [Related]
10. Neurotoxic reaction to citalopram. Thwaites JH; Hutchinson C; Collins C N Z Med J; 2006 Jun; 119(1235):U2019. PubMed ID: 16751836 [No Abstract] [Full Text] [Related]
11. [Letter: Prenylamine and parkinsonian manifestations]. Varenne A Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2044. PubMed ID: 1178454 [No Abstract] [Full Text] [Related]
12. Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression. Sherman TL; McDougle CJ; Price LH Conn Med; 1993 Sep; 57(9):587-92. PubMed ID: 8252846 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptics and family history of Parkinson diseases: case report. Theodoulou G; Milner G; Jumaian A East Mediterr Health J; 2001 May; 7(3):559-61. PubMed ID: 12690781 [No Abstract] [Full Text] [Related]
14. Tardive dyskinesia associated with molindone treatment. Katz SE Am J Psychiatry; 1990 Jan; 147(1):124-5. PubMed ID: 2293775 [No Abstract] [Full Text] [Related]
15. Withdrawal after discontinuation of paroxetine. Arya DK Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183 [No Abstract] [Full Text] [Related]
16. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A; Crawford GM; Angus M; Wilson R; Hamilton L Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891 [TBL] [Abstract][Full Text] [Related]
17. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine]. Krol DG; Nolen WA Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033 [TBL] [Abstract][Full Text] [Related]
18. [Drug of the month. Paroxetine (Seroxar, Aropax)]. Scheen AJ Rev Med Liege; 1994 Apr; 49(4):224-5. PubMed ID: 8209126 [No Abstract] [Full Text] [Related]
19. Comment: paroxetine use during pregnancy: is it safe? Wood W; Einarson A Ann Pharmacother; 2006 Dec; 40(12):2281-2. PubMed ID: 17132812 [No Abstract] [Full Text] [Related]
20. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale]. Torrini M; Masini E; Ledda F; Mannaioni PF Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804 [No Abstract] [Full Text] [Related] [Next] [New Search]